A study in Diabetes, Obesity and Metabolism found patients who discontinued GLP-1 therapy regained about two-thirds of their lost weight within one year
Patients who are eligible to take a GLP-1 drug are also enrolled in Omada's lifestyle modification program, which drives behavioral change
Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and LEADER (REWIND trial reference)
However, overdosing on semaglutide or tirzepatide is a real possibilityand one with potentially life-threatening side effects
If theyre hurt now [because of a training injury], they cant wait for FDA approval. Indeed, regulatory agencies are no fans of these peptides
Yellow or brown discoloration If your semaglutide solution has turned yellow, amber, or brown, it has almost certainly undergone chemical degradation